Analyst stock forecast
Integra LifeSciences Holdings Forecast: $19.56 Analyst Target
IART has a $19.56 target, Hold rating and 9 analysts. As of 2026-08-19.
Direct answer
Integra LifeSciences Holdings's average price target is $19.56.
The target implies +8.3% from the recorded current price, and the consensus rating is Hold.
The low target implies -22.4%, the high target implies +49.6%, and the range spans 72% of the current price.
Forecast evidence checked August 19, 2026.
Get free Integra LifeSciences Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $18.05
- Average price target
- $19.56
- High price target
- $27.00
- Low price target
- $14.00
- Low target gap
- -22.4%
- Target upside
- +8.3%
- High target gap
- +49.6%
- Target range width
- 72%
- Consensus rating
- Hold
- Analysts
- 9
- Evidence date
- August 19, 2026
- Valid through
- August 26, 2026
Explore related company data
Read the frequently asked questions.
What is Integra LifeSciences Holdings's average price target?
Integra LifeSciences Holdings's verified average price target is $19.56. The target range is $14.00 to $27.00.
How far are Integra LifeSciences Holdings's low and high targets from the recorded price?
The low target implies -22.4%, while the high target implies +49.6%.
How many analysts are included in Integra LifeSciences Holdings's consensus?
The verified consensus includes 9 analysts.
How is Integra LifeSciences Holdings's target upside or downside calculated?
The average target of $19.56 is divided by the recorded price of $18.05, then one is subtracted to produce +8.3%. This does not guarantee a future return.
When was Integra LifeSciences Holdings's analyst forecast verified?
The data was verified on 2026-08-19. The dataset is valid through 2026-08-26.